Skip to content

Vilanterol + Umeclidinium + Fluticasone Furoate

Generic Medicine With 2 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Vilanterol + Umeclidinium + Fluticasone Furoate

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

COPD This is indicated in- For the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). For the maintenance treatment of asthma in patients aged 18 years and older.

Dosage And Administration

Adults: 18 years or older: For oral inhalation only. Should be taken by revolizer. Should be used at the same time every day, not more than 1 time every 24 hours. If shortness of breath or other asthma symptoms arise in the period between doses, an inhaled SABA should be taken for immediate relief. Maintenance treatment of COPD: 1 inhalation of cozycap once daily. Maintenance treatment of asthma: 1 inhalation of cozycap once daily. Limitation of use: Not indicated for relief of acute bronchospasm.

Side Effects

COPD: Most common adverse reactions (incidence ≥1%) are upper respiratory tract infection, pneumonia, bronchitis, oral candidiasis, headache, back pain, arthralgia, infuenza, sinusitis, pharyngitis, rhinitis, dysgeusia, constipation, urinary tract infection, diarrhea, gastroenteritis, oropharyngeal pain, cough, and dysphonia. Asthma: Most common adverse reactions (incidence ≥2%) are pharyngitis/nasopharyngitis, upper respiratory tract infection/viral upper respiratory tract infection, bronchitis, respiratory tract infection/viral respiratory tract infection, sinusitis/acute sinusitis, urinary tract infection, rhinitis, infuenza, headache, and back pain.

Precautions And Warnings

LABA monotherapy increases the risk of serious asthma-related events. Do not initiate in acutely deteriorating COPD or asthma. Do not use to treat acute symptoms. Do not use in combination with additional therapy containing a LABA because of risk of overdose. Candida albicans infection of the mouth and pharynx may occur. Monitor patients periodically. Advise the patient to rinse his/her mouth with water without swallowing after inhalation to help reduce the risk. Increased risk of pneumonia in patients with COPD. Monitor patients for signs and symptoms of pneumonia. If paradoxical bronchospasm occurs, discontinue and institute alternative therapy. Use with caution in patients with cardiovascular disorders because of beta-adrenergic stimulation. Worsening of urinary retention may occur. Use with caution in patients with prostatic hyperplasia or bladder-neck obstruction. Use with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, and ketoacidosis.

Pregnancy And Lactation

Insufficient data on the use of this preparation in pregnant women and lactating mothers.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 2

Sorted By
Inhalation Capsule

Trelanti 25 mcg+62.5 mcg+100 mcg

Generic: Vilanterol + Umeclidinium + Fluticasone Furoate

90.00Taka / Unit

View Medicine
Inhalation Capsule

Trihale 25 mcg+62.5 mcg+100 mcg

Generic: Vilanterol + Umeclidinium + Fluticasone Furoate

120.00Taka / Unit

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250